NCT00745407

Brief Summary

Fenofibrate increases adiponectin levels, but reduces leptin levels

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 2005

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 2, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 3, 2008

Completed
Last Updated

September 3, 2008

Status Verified

September 1, 2008

First QC Date

September 2, 2008

Last Update Submit

September 2, 2008

Conditions

Keywords

adipocytokinesinsulin sensitivityhypertriglyceridemic patients

Study Arms (1)

fenofibrate 160 mg, placebo

EXPERIMENTAL
Drug: fenofibrate

Interventions

fenofibrate 160 mg, placebo

Eligibility Criteria

Age25 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • hypertriglyceridemia

You may not qualify if:

  • chronic liver disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gil Medical Center

Incheon, 405760, South Korea

Location

MeSH Terms

Conditions

HypertriglyceridemiaInsulin Resistance

Interventions

Fenofibrate

Condition Hierarchy (Ancestors)

HyperlipidemiasDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHyperinsulinismGlucose Metabolism Disorders

Intervention Hierarchy (Ancestors)

Fibric AcidsIsobutyratesButyratesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsPhenyl EthersEthersBenzophenonesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPhenolsKetones

Study Design

Study Type
interventional
Phase
phase 4
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 2, 2008

First Posted

September 3, 2008

Study Start

January 1, 2005

Study Completion

August 1, 2008

Last Updated

September 3, 2008

Record last verified: 2008-09

Locations